New combo drug may cut painkiller use in ventilated newborns
NCT ID NCT07241351
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding dexmedetomidine (a sedative) to fentanyl (a painkiller) could reduce the amount of fentanyl needed for full-term newborns on breathing machines. Forty babies were given either a lower fentanyl dose plus dexmedetomidine or standard fentanyl alone. Researchers tracked pain scores and how many extra painkiller doses were needed, while watching for side effects like slow heart rate or low blood pressure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexmedetomidine (a sedative) and fentanyl (a painkiller)
- What this could lead to
- If it works, this could help reduce the amount of fentanyl needed for newborns on breathing machines, potentially lowering side effects.
- What could go wrong
- This is a small, early-phase study with only 40 babies. It may not show clear benefits, and risks like slow heart rate or low blood pressure are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
40 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 hour to 28 days
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Full term neonates (≥ 37 weeks gestational age) * Age: 1 to 28 days. * Neonates just started invasive mechanical ventilation and are going to start sedation. Exclusion Criteria: * Presence of central nervous system abnormality * Complex multiple congenital anomalies * Neonates with facial malformations * Neonates on mechanical Ventilation setting (peep above 9)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Analgesia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University Hospitals
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- How much lidocaine reaches a newborn during an urgent C-Section?
- Can a local anesthetic injection curb Kids' pain after tonsil removal?
- Could a small electrical device cut painkiller use after hip surgery?
- Two strong painkillers go Head-to-Head in the ambulance
- Which nerve block eases chest surgery pain better?
- Which epidural technique best handles a cesarean emergency?